OtherArticle
S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite S-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mice model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further VPA hydroxamates and amides
Daniel Eikel, Katrin Hoffmann, Karolin Zoll, Alfonso Lampen and Heinz Nau
Drug Metabolism and Disposition January 25, 2006, DOI: https://doi.org/10.1124/dmd.105.008078
Daniel Eikel
Katrin Hoffmann
Karolin Zoll
Alfonso Lampen
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite S-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mice model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further VPA hydroxamates and amides
Daniel Eikel, Katrin Hoffmann, Karolin Zoll, Alfonso Lampen and Heinz Nau
Drug Metabolism and Disposition January 25, 2006, DOI: https://doi.org/10.1124/dmd.105.008078
OtherArticle
S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite S-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mice model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further VPA hydroxamates and amides
Daniel Eikel, Katrin Hoffmann, Karolin Zoll, Alfonso Lampen and Heinz Nau
Drug Metabolism and Disposition January 25, 2006, DOI: https://doi.org/10.1124/dmd.105.008078
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement